Details of the Drug | DrugMAP

General Information of Drug (ID: DM8Y210)

Drug Name

AIM-102

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C16H27N3O6
Canonical SMILES: C1CCC(CC1)CC(C(=O)NC(CCC(=O)O)C(=O)NCC(=O)O)N
InChI: 1S/C16H27N3O6/c17-11(8-10-4-2-1-3-5-10)15(24)19-12(6-7-13(20)21)16(25)18-9-14(22)23/h10-12H,1-9,17H2,(H,18,25)(H,19,24)(H,20,21)(H,22,23)/t11-,12-/m1/s1
InChIKey: CNDMSQXUUIBFPE-VXGBXAGGSA-N

Cross-matching ID

PubChem CID: 10126114
CAS Number: 551936-17-5
TTD ID: D0B7QU

References

1	ClinicalTrials.gov (NCT01501942) Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma. U.S. National Institutes of Health.